Siegfried Plunges to Loss Despite Rise in API Sales

摘要

Fine chemicals producer Siegfried (Zofingen, Switzerland) has recorded a loss of SF35.3 million ($32.8 million), on sales down 2.2% to SF283 million for full year 2009. The company recorded an Ebitda for the year of SF25.3 million, equivalent to 8.9% of sales, before taking into account write-offs on various reassessed balance sheet items. Sales of active pharmaceutical ingredients (API) rose 15.3% to SF220.9 million. The number of customers placing medium-to-large orders with Siegfried grew in 2009 compared with the year earlier, the company says. A significant supply agreement was signed in the field of controlled substances, including opiates, in the U.S. during the year. A second agreement was signed in the first weeks of the financial year for 2010, the company says. Sales from generic drugs activities fell 36% to SF62.1 million compared to the previous year.